- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04418258
Capillary Endoscopy Aspiration Catheter
Evaluation of a Capillary Endoscopy Aspiration Catheter
The small intestine is an understudied frontier of microbiome research. While aspiration during endoscopy is considered the gold standard to assess small bowel bacteria, the tools for sterile retrieval are primitive and poorly validated.
Endoscopic aspiration is time-consuming and prone to contamination. Inspired by plants' ability to draw water by capillary action, a novel multi-capillary sterile system was designed which is a modified version of the conventional aspiration catheter.
The purpose of this study is to examine the time and volume capabilities of this catheter in suctioning various liquids compared to conventional aspiration catheter, in two groups, each includes 23 patients that going under endoscopy at GI lab at Cedars Sinai Medical Center. The investigator will collect up to 2 ml fluid from Duodenum- in first group by using the conventional catheter and in second group by using the capillary catheter. The time collection and the volume of samples in 2 groups will be compared.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Medically Associated Science and Technology (MAST) program at Cedars-Sinai is dedicated to the development of novel drugs and devices to diagnose and treat patients. This study designed to examine the efficiency of the aspiration capillary catheter during an endoscopy procedure. The investigators want to know if this capillary catheter can suction faster than the current commercially available endoscopic aspiration catheter.
You are being asked to take part in this research study because you are undergoing an endoscopy or esophagogastroduodenoscopy procedure as part of your clinical care.
The study will enroll up to 46 people in total. This research study is designed to test the investigational use of a modified endoscopy aspiration catheter. The original, standard endoscopy aspiration catheter has been approved by the U.S. Food and Drug Administration (FDA), but the investigational catheter used in this study, which is similar in structure, makeup, and function to this approved device, has not been approved by the FDA. During regularly conducted endoscopy procedures, investigators will use either the standard catheter or a different kind of catheter to collect up to 2 ml fluid from the small intestine. The typical catheter used for this procedure is called an endoscopic aspiration catheter. The modified catheter is a capillary aspiration catheter, which is constructed and functions a bit differently. In the lab, this capillary aspiration catheter performs more efficiently, meaning it collects the fluid faster and more successfully than the usual endoscopic aspiration catheter. The investigators hope that using this different catheter will demonstrate the same improved results when used in real situations in humans. The investigators will record how long it takes to suction a sample of the intestinal contents (2 ml, approximately two-fifths of a teaspoon). These samples will be collected solely for research purposes and will be discarded per standard after the procedure.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: MAST Program
- Phone Number: (310) 423-0617
- Email: mastprogram@cshs.org
Study Locations
-
-
California
-
Los Angeles, California, United States, 90048
- Recruiting
- Cedars-Sinai Medical Center
-
Contact:
- Mast Program
- Phone Number: 310-423-7302
- Email: mastprogram@cshs.org
-
Contact:
- Mast Program
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female subjects aged 18-85 undergoing esophagogastroduodenoscopy.
Exclusion Criteria:
- There are no exclusion criteria for this study as subjects will be undergoing the procedures for medical reasons and not for the purposes of this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Capillary Aspiration Endoscopy Catheter group
Small intestine aspirate suction was carried out with a capillary aspiration endoscopy catheter
|
Small intestinal fluid will be suctioned with using a capillary endoscopy aspiration catheter[#CSL2182; Hobbs Medical,Inc.
Connecticut, US] during upper endoscopy
|
Active Comparator: Aspiration endoscopy catheter group
Small intestine aspirate suction was carried out with an aspiration endoscopy catheter
|
Small intestinal fluid will be suctioned with using an endoscopy aspiration catheter[#2182; Hobbs Medical,Inc.
Connecticut, US] during upper endoscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The volume(millilitres) of the aspirate that will be suctioned from small intestine in two groups
Time Frame: 5 minutes
|
The volume(millilitres) of the aspirate that collected from small intestine during upper endoscopy will be the primary end point
|
5 minutes
|
The time(minutes) of the aspirate collection from small intestine will be measured in two groups
Time Frame: 5 minutes
|
The time(minutes) of the aspirate collection from small intestine will be measured in two groups
|
5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The rate of adverse events such as perforation, and bleeding in two groups
Time Frame: 30 minutes
|
The rate of adverse events at 30 minutes after endoscopy
|
30 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ali Rezaie, MD, Cedars-Sinai Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00000319
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Microbiota
-
Microbio Co LtdCompleted
-
University of California, Los AngelesCompleted
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompleted
-
Afyonkarahisar Health Sciences UniversityNot yet recruiting
-
Third Affiliated Hospital, Sun Yat-Sen UniversityCompleted
-
Hadassah Medical OrganizationBar-Ilan University, IsraelWithdrawn
-
Manchester University NHS Foundation TrustUniversity of ManchesterRecruiting
-
University of ManitobaAlmond Board of CaliforniaTerminated
-
Kimberly-Clark CorporationWithdrawn
-
Samara State Medical UniversityRecruitingOral MicrobiotaRussian Federation
Clinical Trials on Capillary Endoscopy Aspiration Catheter
-
Yokohama City University Medical CenterTeikyo UniversityCompleted
-
Cerenovus, Part of DePuy Synthes Products, Inc.CompletedAcute Ischemic StrokeUnited Kingdom, Germany
-
M.D. Anderson Cancer CenterCompletedLymphadenopathyUnited States
-
MIVI Neuroscience, Inc.CompletedStroke, IschemicSpain
-
Radboud University Medical CenterDutch Heart Foundation; Penumbra Inc.CompletedIntracerebral Hemorrhage | Surgical Procedures, Minimally InvasiveNetherlands
-
National Institute of Cardiovascular Diseases,...MedtronicRecruitingST-segment Elevation Myocardial Infarction (STEMI) | Total Occlusion of Coronary Artery | Primary Percutaneous Coronary InterventionPakistan
-
Lumen BiomedicalCompletedFresh Soft Emboli or Thrombi in the Arteries.New Zealand
-
University of Maryland, BaltimoreInari MedicalNot yet recruitingThrombosis | Thrombectomy | Portal Vein
-
Niguarda HospitalCompletedAcute Myocardial InfarctionItaly
-
Newcastle-upon-Tyne Hospitals NHS TrustCompletedAcute ST Elevation Myocardial InfarctionUnited Kingdom